CS logo
small CS logo
Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)

Nizhny Novgorod, Nizhegorodskaya Oblast, Russian Federation
General hospital in Nizhny Novgorod
Ulitsa Goncharova, 1Д, Nizhny Novgorod, Nizhny Novgorod Oblast, 603032

About Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
2
Total Rows: 1

Clinical Trials at Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)


During the past decade, Volga District Medical Center Federal Medical and Biological Agency ( Site 0857) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200Started TrialsCompleted Trails20190123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
2019-06-13
2025-06-15
Active, not recruiting
907
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
2019-07-24
2027-12-15
Recruiting
857

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" #1 collaborator was "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsMerck Sharp & Dohme LLC: 2Merck Sharp & Dohme LLC: 2

Created with Highcharts 11.1.0Top CollaboratorsAstellas Pharma GlobalDevelopment, Inc.: 1Astellas Pharma GlobalDevelopment, Inc.: 1Seagen Inc.: 1Seagen Inc.: 1

Clinical Trials Conditions at Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)


According to Clinical.Site data, the most researched conditions in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" are "Urinary Bladder Cancer, Muscle-invasive" (2 trials). Many other conditions were trialed in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" in a lesser frequency.

Clinical Trials Intervention Types at Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)


Most popular intervention types in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Pembrolizumab" (2 trials), "Surgery (radical cystectomy (RC) plus Pelvic Lymph Node Dissection [PLND])" (2 trials), "Cisplatin" (1 trials), "Enfortumab Vedotin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)


The vast majority of trials in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)" are 2 trials for "All" genders.

Clinical Trials Status at Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)


Currently, there are NaN active trials in "Volga District Medical Center Federal Medical and Biological Agency ( Site 0857)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Volga District Medical Center Federal Medical and Biological Agency ( Site 0857), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Volga District Medical Center Federal Medical and Biological Agency ( Site 0857), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1